India  

Covaxin generated excellent safety data, says Bharat Biotech

Mid-Day Monday, 4 January 2021
Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat Biotech claimed on Sunday that its vaccine generated excellent safety data with robust immune responses to multiple viral proteins that persist.

Covaxin is a highly...
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: Bharat Biotech have tremendous experience in vaccines: MD Dr Krishna

Bharat Biotech have tremendous experience in vaccines: MD Dr Krishna 01:32

While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna Ella said, "We are not a company without experience in vaccines. We have tremendous experience in vaccines. We are...

You Might Like


Related videos from verified sources

'Who will opt for vaccine...': Congress questions approval, slams govt [Video]

'Who will opt for vaccine...': Congress questions approval, slams govt

Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'. Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid..

Credit: HT Digital Content     Duration: 03:25Published
Just for 'Atmanirbhar Bharat', govt licensed Covaxin despite pending trials: Manish Tewari [Video]

Just for 'Atmanirbhar Bharat', govt licensed Covaxin despite pending trials: Manish Tewari

: Congress leader Manish Tewari slammed Centre for licensing the Bharat Biotech's vaccine candidate for COVID-19, Covaxin, despite the final phase trials not being completed. "The BJP government has..

Credit: ANI     Duration: 01:36Published
'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy [Video]

'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy

Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella, addressed a virtual conference amid doubts from some quarters regarding approval of the vaccine developed by the Indian company. On..

Credit: HT Digital Content     Duration: 08:59Published